The DOI matches its Crossref record; 205 of the 208 references it cites were found in a registry or an index.
Age-Related Changes in Glucose Metabolism, Hyperglycemia, and Cardiovascular Risk
Open accessAbstract
Aging and diabetes mellitus are 2 well-known risk factors for cardiovascular disease (CVD). During the past 50 years, there has been an dramatic increase in life expectancy with a simultaneous increase in the prevalence of diabetes mellitus in the older population. This large number of older individuals with diabetes mellitus is problematic given that CVD risk associated with aging and diabetes mellitus. In this review, we summarize epidemiological data relating to diabetes mellitus and CVD, with an emphasis on the aging population. We then present data on hyperglycemia as a risk factor for CVD and review the current knowledge of age-related changes in glucose metabolism. Next, we review the role of obesity in the pathogenesis of age-related glucose dysregulation, followed by a summary of the results from major randomized controlled trials that focus on cardiovascular risk reduction through glycemic control, with a special emphasis on older adults. We then conclude with our proposed model of aging that body composition changes and insulin resistance link possible dysregulation of physiological pathways leading to obesity and diabetes mellitus—both forms of accelerated aging—and risks for CVD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Many factors participate in the metabolic dysregulation that develops with increasing age, and changes in body composition make an important contribution (100).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–205 of 205
THE PANCREATIC BETA‐CELL RESPONSE TO INTRAVENOUS ADMINISTRATION OF GLUCOSE IN ELDERLY SUBJECTS*
Sangiorgi, G. B., Laudicina, E., Bompiani, G., & Durante, F. R. (1970) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1970.tb02786.x · Cited by 14
Glucagon-Like Peptide-1 (7-37) Augments Insulin Release in Elderly Patients With Diabetes
Meneilly, G. S., McIntosh, C. H. S., Pederson, R. A., Habener, J. F., Gingerich, R. L., Egan, J. M., & Elahi, D. (2001) · Diabetes Care · doi:10.2337/diacare.24.5.964 · Cited by 13
Self-citationAssessment of the new criteria for diabetes mellitus according to 10-year relative survival rates
Sasaki, A. (1981) · Diabetologia · doi:10.1007/bf00252627 · Cited by 10
Knatterud, G. L. (1978) · JAMA · doi:10.1001/jama.1978.03290010041020 · cited 1×
“The study was continued in the 2 insulin groups because their macrovascular or microvascular complications and mortality were no different from placebo; however, results remained the same after 13 years of follow-up with no obvious benefit to insulin treatment in either insulin groups.(186,187) In the 2000s, thiazoled…”
Research works printed but not linked: 4
- He, W, Goodkind, D, Kowal, P. An Aging World: 2015; International Population Reports. 2016. US Census Bureau, US Government Printing Office: Washington D.C.
- 10.1001/jama.1971.03190220020005 · DOI
- 10.1001/jama.1971.03190060017005 · DOI
- Knatterud, GL, Klimt, CR, Goldner, MG, Hawkins, BS, Weisenfeld, S, Kreines, K, Haddock, L. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes.V. Evaluation of phenformin therapy. Diabetes. 1975;24:65–184.
Cited by
Sorted by citations
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939
Type 2 diabetes mellitus in older adults: clinical considerations and management
Bellary, S., Kyrou, I., Brown, J. E., & Bailey, C. J. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00512-2 · Cited by 639
Healthcare on the brink: navigating the challenges of an aging society in the United States
Jones, C. H., & Dolsten, M. (2024) · npj Aging · doi:10.1038/s41514-024-00148-2 · Cited by 439
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Islam, M. T., Tuday, E., Allen, S., Kim, J., Trott, D. W., Holland, W. L., Donato, A. J., & Lesniewski, L. A. (2023) · Aging Cell · doi:10.1111/acel.13767 · Cited by 313
Metadata
- Authors
- Chia, C. W., Egan, J. M., & Ferrucci, L.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Ferrucci, Luigi
- Venue
- Circulation Research
- Published
- 2018-09-14
- Volume
- 123
- Issue
- 7
- Pages
- 886-904
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- PMC
- PMC6205735
- OpenAlex
- W2891409258
- Semantic Scholar
- 5a8e379d2aa3e6281c5204edc4fa23822ef37775
- Cited by
- 454
- References
- 208
- Citations by year
- 2026: 61 · 2025: 71 · 2024: 72 · 2023: 82 · 2022: 70 · 2021: 38 · 2020: 42 · 2019: 15 · 2018: 1
- FWCI
- 3.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (Z01AG000015)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- aging, glucose metabolism, hyperglycemia, cardiovascular risk, diabetes mellitus, older adults, obesity, insulin resistance, glycemic control, body composition, accelerated aging, cardiovascular disease
- MeSH terms
- Adipose Tissue, Age Factors, Aging, Animals, Blood Glucose, Cardiovascular Diseases, Health Status, Humans, Hyperglycemia, Insulin, Insulin Resistance, Models, Biological, Obesity, Prognosis, Risk Factors, Biomarkers, Prevalence, Risk Assessment, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
